There appears to be an increase in Tim-3 expression on tumour-infiltrating CD4+ T cells and a significant increase on CD8+ T cells compared with circulating levels in the treatment-naïve setting (p = 0.06 and p = 0.009) (Fig. 1E.). This evidence concerns the gene HAVCR2 and neoplasm.